Breast cancer epidemiology, prevention, and early detection.

Abstract:

:Breast cancer remains a worldwide public health concern despite the fact that mortality rates have been declining in some countries as a result of improvements in adjuvant therapy and screening for breast cancer. In the prevention arena, advances in our understanding of the effects of tamoxifen have led to the investigations of newer agents that may provide extended options for breast cancer prevention in high-risk women. For women who are carriers of a mutation in the breast cancer susceptibility genes BRCA1 or BRCA2, prophylactic oophorectomy and bilateral mastectomy have emerged as preventative surgical options that can significantly impact breast cancer risk. In addition, the identification of potentially modifiable risk factors for breast cancer such as dietary folate intake, alcohol consumption, physical activity, and certain anthropometric factors provides opportunities for intervening in breast cancer prevention both among women at average and high risk. The challenge remains in overcoming the limitations of mammography and clinical breast examination by developing and evaluating new technologies for breast cancer screening such as digital mammogram and breast magnetic resonance imaging.

journal_name

Curr Opin Oncol

authors

Brewster A,Helzlsouer K

doi

10.1097/00001622-200111000-00002

keywords:

subject

Has Abstract

pub_date

2001-11-01 00:00:00

pages

420-5

issue

6

eissn

1040-8746

issn

1531-703X

journal_volume

13

pub_type

杂志文章,评审
  • Therapy for small cell and non-small cell lung cancer.

    abstract::This review addresses means for improving treatment results in small cell and non-small cell lung cancer. In small cell lung cancer lactate dehydrogenase and neuron-specific enolase seem to be important prognostic factors that may reflect not only tumor load but also growth rate. Chemotherapy seems to induce or select...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00013

    authors: Splinter TA

    更新日期:1992-04-01 00:00:00

  • Pralatrexate: an emerging new agent with activity in T-cell lymphomas.

    abstract:PURPOSE OF REVIEW:T-cell lymphomas (TCL) represent a particularly poor prognosis subgroup of lymphomas. The goal of this review is to provide emerging information on one agent demonstrating activity in these challenging diseases. Pralatrexate is a novel antifolate designed to have high affinity for the reduced folate c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000245309.74767.20

    authors: O'Connor OA

    更新日期:2006-11-01 00:00:00

  • Testicular cancer.

    abstract::In testicular cancer epidemiology, the increasing recognition that germinal epithelial atrophy is the final common pathway in the development of this tumor has developed along with reports that elevated follicule-stimulating hormone levels at the time of diagnosis of first tumor correlate with risk of developing a sec...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Oliver RT

    更新日期:1991-06-01 00:00:00

  • Testicular germ cell tumors.

    abstract:PURPOSE OF REVIEW:An overview of many of the preclinical and clinical developments in germ cell tumors over the past year is presented. RECENT FINDINGS:Recent epidemiologic studies show changes in the ethnic incidence of germ cell tumors; in particular, African-Americans have seen an increase. Additionally, risk facto...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000219257.37843.ca

    authors: Bridges B,Hussain A

    更新日期:2006-05-01 00:00:00

  • Graft-versus-host disease.

    abstract::Graft-versus-host disease (GVHD) continues to be a major obstacle to the success of allogeneic bone marrow transplantation. Furthermore, several clinical strategies being employed at this time in the field of bone marrow transplantation have had an impact on GVHD. In addition to the usual division of topics such as pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199703000-00005

    authors: Marcellus DC,Vogelsang GB

    更新日期:1997-03-01 00:00:00

  • Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.

    abstract::The vast majority of adults with acute lymphoblastic leukemia (ALL) now achieve remission with current intensive chemotherapy regimens. Nevertheless, most adults with ALL will eventually relapse and die of their disease. Specific clinical and molecular-cytogenetic prognostic factors have been identified that are begin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200101000-00004

    authors: Verma A,Stock W

    更新日期:2001-01-01 00:00:00

  • Palliative care of patients with terminal cancer.

    abstract::Palliative (terminal) care is now recognized worldwide as an important, multidisciplinary aspect of the continuing care of patients with incurable cancer. Symptom control and quality-of-life are of the essence. Various treatment methods are available, and radiotherapy and chemotherapy (used appropriately) are importan...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199307000-00006

    authors: Hancock BW,Ahmedzai S,Clark D

    更新日期:1993-07-01 00:00:00

  • Pathology of squamous carcinomas of the head and neck.

    abstract::Recent publications dealing with the pathology of squamous carcinomas of the head and neck have been critically reviewed with particular reference to potential prognostic factors and improved methods for identifying nodal metastases. The topics covered include cytophotometry and proliferative patterns, molecular biolo...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199305000-00009

    authors: Carter RL

    更新日期:1993-05-01 00:00:00

  • Treatment of AIDS-related lymphomas.

    abstract::Infection with HIV is associated with an increased risk of systemic and primary central nervous system non-Hodgkin's lymphoma. Patients with systemic non-Hodgkin's lymphoma usually present with high- or intermediate-grade histology and extranodal dissemination. Although the prognosis for such patients is poor, some pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Sparano JA

    更新日期:1995-09-01 00:00:00

  • Human papillomavirus-associated anogenital neoplasia and other solid tumors in human immunodeficiency virus-infected individuals.

    abstract::The incidence and variety of solid tumors reported among human immunodeficiency virus (HIV)-infected individuals are increasing. Among the most common of these tumors are anogenital malignant and premalignant tumors associated with human papillomavirus infection. Cervical intraepithelial neoplasia is one such human pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199110000-00012

    authors: Palefsky JM

    更新日期:1991-10-01 00:00:00

  • Outpatient therapy for febrile neutropenia.

    abstract:PURPOSE OF REVIEW:The management of febrile neutropenia has evolved significantly with the development of risk stratification and recognition of the efficacy of oral antibiotics in low-risk patients. There remains uncertainty concerning the need for hospitalization and role of early hospital discharge. We review recent...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3281214436

    authors: Innes H,Marshall E

    更新日期:2007-07-01 00:00:00

  • Treatment advances in adult Burkitt lymphoma and leukemia.

    abstract:PURPOSE OF REVIEW:Despite significant improvements in the treatment of Burkitt lymphoma, outcomes of adults are generally inferior to those of children. This review summarizes the most recent developments in the management of Burkitt lymphoma and leukemia in adults. RECENT FINDINGS:Current regimens have largely been d...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200409000-00003

    authors: Kasamon YL,Swinnen LJ

    更新日期:2004-09-01 00:00:00

  • Bisphosphonates in cancer therapy.

    abstract::Bisphosphonates inhibit osteoclast-mediated bone resorption in metastatic bone disease. A wealth of preclinical data have begun to shed light on the complex mechanisms by which bisphosphonates inhibit bone resorption and interfere with the formation and growth of bone metastases. Nitrogen-containing bisphosphonates in...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200211000-00004

    authors: Green JR

    更新日期:2002-11-01 00:00:00

  • Palliative care in glioma management.

    abstract:PURPOSE OF REVIEW:The concept of palliative care is becoming increasingly important in the management of glioma patients. However, the right time for implementation, as well as the individual degree of integration of palliative care aspects, are still a matter of debate. This review updates recent evidence of palliativ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000584

    authors: Oberndorfer S,Hutterer M

    更新日期:2019-11-01 00:00:00

  • Reclassifying endometrial carcinomas with a combined morphological and molecular approach.

    abstract:PURPOSE OF REVIEW:Currently, endometrial carcinoma diagnosis is based on morphology, often supplemented by immunohistochemistry. However, especially with high-grade endometrial carcinomas, there is considerable interobserver variability in diagnosis calling into question the value of morphology in stratifying these tum...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000560

    authors: Carlson J,McCluggage WG

    更新日期:2019-09-01 00:00:00

  • Environmental estrogens and breast cancer risk.

    abstract::Controversy exists over the role that environmental estrogens, such as pesticides or polychlorinated biphenyls (PCBs), might play as risk factors for breast cancer. Several laboratory studies have suggested that these chemicals function as weak estrogens, binding to the estrogen receptor and inducing various measures ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199809000-00018

    authors: Davidson NE

    更新日期:1998-09-01 00:00:00

  • Cutaneous T-cell lymphomas.

    abstract::Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated. Multimodality trea...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199309000-00007

    authors: Kaplan EH,Leslie WT

    更新日期:1993-09-01 00:00:00

  • Preclinical studies, experimental therapeutics, and clinical management of advanced melanoma.

    abstract::The preclinical and clinical investigations of therapeutic approaches to melanoma have progressed significantly in the past year. This article reviews recently published information relevant to preclinical studies of the biologic function of stromal tissue, growth factors (and receptors), interferons, cytokines, and a...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00020

    authors: Kirkwood JM

    更新日期:1992-04-01 00:00:00

  • Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes.

    abstract:PURPOSE OF REVIEW:We used two examples of genes, TP53 and EGFR, which are somatically altered by intragenic mutations in common cancer types to illustrate how somatic mutations have followed very different routes to clinical applications. RECENT FINDINGS:TP53 somatic mutations are frequent in many cancers. Their progn...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283412dfa

    authors: Olivier M,Taniere P

    更新日期:2011-01-01 00:00:00

  • The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

    abstract:PURPOSE OF REVIEW:To review recent observations that describe changes in the likelihood of invasive fungal infections, shifts in types of fungal pathogens, and altered manifestations of fungal syndromes after hematopoietic cell transplantation and explore how changes in transplant practices are influencing these epidem...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000152975.65477.7c

    authors: Wingard JR

    更新日期:2005-03-01 00:00:00

  • Metastatic breast cancer.

    abstract::Tamoxifen as adjuvant systemic treatment after first isolated locoregional recurrence of breast cancer has been shown to decrease the subsequent locoregional relapse rate, but it affects neither distant metastases nor survival. In metastatic disease, tamoxifen has not improved response when added to ablation of ovaria...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199511000-00008

    authors: Rubens RD

    更新日期:1995-11-01 00:00:00

  • Adjuvant therapy for melanoma.

    abstract::The search for effective adjuvant therapy for melanoma has resulted in the testing of a remarkably broad spectrum of therapeutic agents. Until recently, there was little evidence to suggest a benefit for any adjuvant therapy. The demonstration of activity for adjuvant high-dose interferon alfa in a cooperative group t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199703000-00015

    authors: Sondak VK,Wolfe JA

    更新日期:1997-03-01 00:00:00

  • Update on the taxoids and other new agents in head and neck cancer therapy.

    abstract::Both paclitaxel and docetaxel have shown activity when used as a single agent in patients with squamous cell carcinoma of the head and neck (SCCHN). Combinations of both drugs with platinum derivatives and antimetabolites have been tested in patient populations with encouraging results, but some have exhibited conside...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199805000-00010

    authors: Schrijvers D,Vermorken JB

    更新日期:1998-05-01 00:00:00

  • The role of radiation in retroperitoneal sarcomas: a surgical perspective.

    abstract:PURPOSE OF REVIEW:This review focuses on the current concepts relating to the use of radiation therapy in the care of surgical patients with retroperitoneal sarcoma. Radiation therapy for retroperitoneal sarcoma patients is complex because it requires decisions on not only the timing of administration, but also the tec...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328122d757

    authors: Pawlik TM,Ahuja N,Herman JM

    更新日期:2007-07-01 00:00:00

  • Recent advances in systemic therapy for breast cancer.

    abstract::During the past year there have been a number of important advances in the area of systemic therapy for breast cancer. Combined chemoendocrine therapy has been shown to be more effective than tamoxifen alone in the adjuvant therapy of node-negative estrogen receptor-positive breast cancer. Preliminary results of a ran...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199811000-00007

    authors: Dees EC,Kennedy MJ

    更新日期:1998-11-01 00:00:00

  • Immunotherapy-based combinations: an update.

    abstract:PURPOSE OF REVIEW:The advent of immunotherapy significantly improved clinical outcomes in cancer patients, although immune checkpoint blockade (ICB) still lack of efficacy in a consistent proportion of treated patients. The purpose of this article is to review the most innovative and clinically promising ICB-based comb...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000466

    authors: Fucà G,de Braud F,Di Nicola M

    更新日期:2018-09-01 00:00:00

  • Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.

    abstract:PURPOSE OF REVIEW:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) constitute a diverse group of neoplasms arising from the diffuse neuroendocrine cell system. During the last 2 years a new classification system, the WHO 2010, has come into clinical practice together with Tumor Nodes Metastases (TNM) staging and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328353d7ba

    authors: Oberg K

    更新日期:2012-07-01 00:00:00

  • Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.

    abstract:PURPOSE OF REVIEW:Melanoma has proven resistant to most available chemotherapy and immunotherapy. Despite a range of different biochemical targets, most agents kill cancer cells by induction of apoptosis. RECENT FINDINGS:Investigation of this process has provided insights into the resistance mechanisms in cancer cells...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000208794.24228.9f

    authors: Hersey P

    更新日期:2006-03-01 00:00:00

  • Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer.

    abstract::The incidence of lung cancer continues to rise. The need and demand for more effective treatment to improve survival and palliate symptoms increases at a great rate. The most recent evidence for the use of chemotherapy in the palliative setting is summarized in this review of the literature from the last few years. It...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200207000-00002

    authors: Medley L,Cullen M

    更新日期:2002-07-01 00:00:00

  • Renal cell carcinoma.

    abstract::Renal cell carcinoma remains a devastating disease known for insidious onset, with patients often having advanced incurable disease at the time of diagnosis. Biologic therapy with IL-2 offers a chance for prolonged remission for a minority of patients, but its toxicities preclude most patients from ever receiving it. ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199505000-00013

    authors: Savage PD

    更新日期:1995-05-01 00:00:00